Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term

Encompass Health (EHC), a leading provider of integrated inpatient rehabilitation services, is highlighted as a top growth stock, holding a Zacks Rank #2 (Buy) with strong Style Scores, including a VGM of B and Growth of B. The company is projected for 18.3% year-over-year earnings growth for the current fiscal year, supported by seven upward analyst revisions for fiscal 2025 estimates, which increased the Zacks Consensus Estimate by $0.23 to $5.24 per share. EHC also boasts a historical average earnings surprise of +14%, positioning it as a compelling opportunity for growth-focused investors.

Analysis

Encompass Health (EHC) presents a compelling growth profile based on strong quantitative ratings and positive analyst sentiment. The company holds a Zacks Rank #2 (Buy), complemented by a 'B' grade for both its Growth and overall VGM Style Scores, indicating favorable characteristics for growth-oriented investors. This outlook is substantiated by a forecast for 18.3% year-over-year earnings growth in the current fiscal year. Furthermore, analyst confidence in its future performance is visibly strengthening, with seven upward earnings estimate revisions for fiscal 2025 within the last 60 days. These revisions have elevated the Zacks Consensus Estimate for fiscal 2025 by $0.23 to $5.24 per share. The company's operational execution is also noteworthy, as evidenced by a historical average earnings surprise of +14%, suggesting a consistent ability to exceed market expectations. EHC's business model, focused on a large network of inpatient rehabilitation hospitals, appears well-positioned to capitalize on the healthcare industry's shift towards integrated care and value-based payment models.

Key Decisions for Investors

• Given the combination of a #2 (Buy) rank, strong growth score, and upward earnings revisions, investors with a growth-oriented strategy should consider EHC a candidate for their watchlist or portfolio.
• Monitor upcoming earnings announcements to verify if the company's 18.3% projected growth materializes and if its +14% average earnings surprise trend continues, which would further validate the bullish thesis.
• Investors should assess EHC's performance relative to the broader healthcare services sector, as its positioning to benefit from integrated payment models like accountable care organizations could serve as a durable competitive advantage.